EUVIMEDEUVIMED entdecken
Crossref

Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators

Zhanyu Wang, Chengming Liu, Sufei Zheng, Yuxin Yao, Sihui Wang, Xinfeng Wang, Enzhi Yin, Qingpeng Zeng, Chaoqi Zhang, Guochao Zhang, Wei Tang, Bo Zheng und 8 weitere

Cancer Cell · 2024-06 · 42 (6) · 1106-1125.e8

DOI: 10.1016/j.ccell.2024.05.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2024-06. Verfasst von Zhanyu Wang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences, Chinese Academy of Meteorological Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine carcinomas (NECs) are extremely lethal malignancies that can arise at almost any anatomic site. Characterization of NECs is hindered by their rarity and significant inter- and intra-tissue heterogeneity. Herein, through an integrative analysis of over 1,000 NECs originating from 31 various tissues, we reveal their tissue-independent convergence and further unveil molecular divergence driven by distinct transcriptional regulators. Pan-tissue NECs are therefore categorized into five intrinsic subtypes defined by ASCL1, NEUROD1, HNF4A, POU2F3, and YAP1. A comprehensive portrait of these subtypes is depicted, highlighting subtype-specific transcriptional programs, genomic alterations, evolution trajectories, therapeutic vulnerabilities, and clinicopathological presentations. Notably, the newly discovered HNF4A-dominated subtype-H exhibits a gastrointestinal-like signature, wild-type RB1, unique neuroendocrine differentiation, poor chemotherapeutic response, and prevalent large-cell morphology. The proposal of uniform classification paradigm illuminates transcriptional basis of NEC heterogeneity and bridges the gap across different lineages and cytomorphological variants, in which context-dependent prevalence of subtypes underlies their phenotypic disparities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, NeuroendocrineGene Expression Regulation, NeoplasticHumansTranscription FactorsBasic Helix-Loop-Helix ProteinsYAP-Signaling ProteinsHepatocyte Nuclear Factor 4Biomarkers, Tumor

Stichwörter der Autor:innen

ASCL1HNF4ANEUROD1Neuroendocrine carcinomaPOU2F3YAP1molecular subtypesmall-cell lung cancertranscriptional factortumor heterogeneity

Substanzen

Transcription FactorsBasic Helix-Loop-Helix ProteinsYAP-Signaling ProteinsHepatocyte Nuclear Factor 4Biomarkers, TumorASCL1 protein, humanYAP1 protein, humanHNF4A protein, humanNEUROD1 protein, human

Autor:innen und Institutionen

  • Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China; Stat…
  • Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 51…
  • Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China.
  • Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China.
  • Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China.
  • Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China.

Förderung

  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences
  • Chinese Academy of Meteorological Sciences
  • Beijing Municipal Science and Technology Commission

Zitieren

APA

Wang, Z., Liu, C., Zheng, S., Yao, Y., Wang, S., Wang, X., Yin, E., Zeng, Q., Zhang, C., Zhang, G., Tang, W., Zheng, B., Xue, L., Wang, Z., Feng, X., Wang, Y., Ying, J., Xue, Q., Sun, N., & He, J. (2024). Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators. Cancer Cell, 42(6), 1106-1125.e8. https://doi.org/10.1016/j.ccell.2024.05.002

Vancouver

Wang Z, Liu C, Zheng S, Yao Y, Wang S, Wang X, et al. Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators. Cancer Cell. 2024;42(6):1106-1125.e8. doi:10.1016/j.ccell.2024.05.002

BibTeX
@article{Wang2024,
  author = {Wang, Zhanyu and Liu, Chengming and Zheng, Sufei and Yao, Yuxin and Wang, Sihui and Wang, Xinfeng and Yin, Enzhi and Zeng, Qingpeng and Zhang, Chaoqi and Zhang, Guochao and Tang, Wei and Zheng, Bo and Xue, Liyan and Wang, Zhen and Feng, Xiaoli and Wang, Yan and Ying, Jianming and Xue, Qi and Sun, Nan and He, Jie},
  title = {Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators},
  journal = {Cancer Cell},
  year = {2024},
  volume = {42},
  number = {6},
  pages = {1106--1125.e8},
  doi = {10.1016/j.ccell.2024.05.002}
}
Kostenlos starten →